Why the study?
To verify whether the area under the curve of the internal carotid artery (AUC-ICA) Doppler wave can serve as a useful marker for assessing insulin resistance in PCOS patients treated with metformin over 6 months.
The area under the curve of the internal carotid artery Doppler wave may serve as a reliable surrogate marker for assessing insulin resistance in women with PCOS during metformin therapy.
AUC-ICA may offer a cost-effective IR marker in metformin-treated PCOS; leaves open prospective validation before clinical adoption.
BACKGROUND: Insulin resistance (IR) was reported in most polycystic ovarian syndrome (PCOS) cases. Metformin, a biguanide drug, successfully reduced IR. Homeostatic Model Assessment for IR (HOMA-IR) and Doppler parameters assessed metformin's effectiveness. AIM: To verify whether the area under the curve of the internal carotid artery (AUC-ICA) Doppler wave can be a useful marker for assessing IR among PCOS cases who presented with menstrual irregularity and were treated with metformin over 6 mo. METHODS: An observational, cross-sectional study recruited 54 eligible PCOS women; the anthropometrics were as follows: age, body mass index (BMI), menstrual cycle days, biochemical serum cholesterol, low and high-density lipoprotein, sex hormone-binding globulin, fasting blood glucose, and HOMA-IR, hormonal testosterone, luteinizing hormone over follicle-stimulating hormone ratio, and ultrasonic pulsatility index (PI) and resistance index (RI), carotid artery intima-media thickness (CIMT) and (AUC-ICA) parameters were initially recorded and repeated 3 mo and 6 mo later with metformin tab 500 mg; three times/day for 6 mo. In addition, AUC-ICA was assessed by taking repeated systolic and diastolic wave height measurements. RESULTS: the best subset regression model, the AUC-ICA had the highest predictive value for HOMA-IR. CONCLUSION: AUC-ICA preceded PI, RI, and CIMT with a strong, meaningful correlation to all PCOS parameters, making it a reliable marker for the assessment of IR, especially during metformin therapy. Further studies are recommended to promote the application in practice.
No takes yet. Share an insight, caveat, or question.
Akram et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: